FDA under pressure to 'open the floodgates' for biogenerics
Spurred on by the frustration of drug manufacturers, governors from four US states have petitioned the US Food and Drug Administration (FDA) for clarity in their requirements for the production of generic versions of insulin and human growth hormone...